{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:13:15Z","timestamp":1787062395042,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Danish Cystic Fibrosis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12931-017-0592-z","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T10:23:13Z","timestamp":1496139793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Electronic applications for the CFQ-R scoring"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8960-7524","authenticated-orcid":false,"given":"Andreas","family":"Ronit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Argentiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Quittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"592_CR1","volume-title":"Guidance for industry patientreported outcome measures: Use in medical product development to support labeling claims","author":"U.S. Food and Drug Administration","year":"2009","unstructured":"U.S. Food and Drug Administration. Guidance for industry patientreported outcome measures: Use in medical product development to support labeling claims. 2009. Availible at: \nhttp:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm193282.pdf\n\n. Accessed 20 Jan 2017."},{"key":"592_CR2","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/S1470-2045(16)30113-9","volume":"17","author":"P Venkatesan","year":"2016","unstructured":"Venkatesan P. New European guidance on patient-reported outcomes. Lancet Oncol. 2016;17:e226.","journal-title":"Lancet Oncol"},{"key":"592_CR3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","volume":"135","author":"GZ Retsch-Bogart","year":"2009","unstructured":"Retsch-Bogart GZ, Quittner AL, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, Cooper PJ. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest. 2009;135:1223\u201332.","journal-title":"Chest"},{"key":"592_CR4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s11136-015-1168-3","volume":"25","author":"N Black","year":"2016","unstructured":"Black N, Burke L, Forrest CB, Sieberer UH, Ahmed S, Valderas JM, Bartlett SJ, Alonso J. Patient-reported outcomes: pathways to better health, better services, and better societies. Qual Life Res. 2016;25:1103\u201312.","journal-title":"Qual Life Res"},{"key":"592_CR5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","volume":"21","author":"CF Snyder","year":"2012","unstructured":"Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve DM, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21:1305\u201314.","journal-title":"Qual Life Res"},{"key":"592_CR6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1513\/pats.200703-039BR","volume":"4","author":"CH Goss","year":"2007","unstructured":"Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc. 2007;4:378\u201386.","journal-title":"Proc Am Thorac Soc"},{"key":"592_CR7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11136-011-0036-z","volume":"21","author":"AL Quittner","year":"2012","unstructured":"Quittner AL, Sawicki GS, McMullen A, Rasouliyan L, Pasta DJ, Yegin A, Konstan MW. Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample. Qual Life Res. 2012;21:1267\u201378.","journal-title":"Qual Life Res"},{"key":"592_CR8","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","volume":"128","author":"AL Quittner","year":"2005","unstructured":"Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347\u201354.","journal-title":"Chest"},{"key":"592_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1022037320039","volume":"12","author":"B Henry","year":"2003","unstructured":"Henry B, Aussage P, Grosskopf C, Goehrs JM. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res. 2003;12:63\u201376.","journal-title":"Qual Life Res"},{"key":"592_CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chest.2016.05.029","volume":"150","author":"M Gelpi","year":"2016","unstructured":"Gelpi M, Argentiero J, Jones PW, Ronit A. A Scoring Application for the St. George\u2019s Respiratory Questionnaire. Chest. 2016;150:747\u20138.","journal-title":"Chest"},{"key":"592_CR11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11136-015-1110-8","volume":"25","author":"C Rutherford","year":"2016","unstructured":"Rutherford C, Costa D, Mercieca-Bebber R, Rice H, Gabb L, King M. Mode of administration does not cause bias in patient-reported outcome results: a meta-analysis. Qual Life Res. 2016;25:559\u201374.","journal-title":"Qual Life Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-017-0592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T10:23:16Z","timestamp":1496139796000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-017-0592-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1186\/s12931-017-0592-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"article-number":"108"}}